Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Tenax Therapeutics, Inc.
13G/A
Amendment 1
TENX · 88032L605
|
0% |
9/11/2026
Event 9/3/2026
|
|||
| ING Groep N.V. | 0% | ||||
| ING Capital Markets LLC | 0% | ||||
|
Tenax Therapeutics, Inc.
13G
TENX · 88032L605
|
7.1% |
8/27/2026
Event 8/19/2026
|
|||
| ING Groep N.V. | 7.1% | ||||
| ING Capital Markets LLC | 7.1% | ||||
|
Neogen Corp
13G/A
Amendment 1
NEOG · 640491106
|
4.0% |
12/4/2025
Event 11/28/2025
|
|||
| ING Groep NV | 4.0% | ||||
| ING Capital Markets LLC | 4.0% | ||||
|
Neogen Corp
13G
NEOG · 640491106
|
6.5% |
10/22/2025
Event 9/29/2025
|
|||
| ING Groep NV | 6.5% | ||||
| ING Capital Markets LLC | 6.5% | ||||